Array comparative genomic hybridization in retinoma and retinoblastoma tissues

Cancer Science

Volumn 100, Issue 3, 2009, Pages 465-471

  Sampieri, Katia ^a   Amenduni, Mariangela ^a   Papa, Filomena Tiziana ^a   Katzaki, Eleni ^a   Mencarelli, Maria Antonietta ^a   Marozza, Annabella ^a   Epistolato, Maria Carmela ^a   Toti, Paolo ^a   Lazzi, Stefano ^a   Bruttini, Mirella ^a   De Filippis, Roberta ^a   De Francesco, Sonia ^a   Longo, Ilaria ^a   Meloni, Ilaria ^a   Mari, Francesca ^a   Acquaviva, Antonio ^a   Hadjistilianou, Theodora ^a   Renieri, Alessandra ^a   Ariani, Francesca ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

S PHASE KINASE ASSOCIATED PROTEIN 2; ANTIIDIOTYPIC ANTIBODY; RETINOBLASTOMA PROTEIN;

AGE DISTRIBUTION; ARTICLE; CANCER TISSUE; CHILD; CHROMOSOMAL INSTABILITY; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME 2P; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MOLECULAR CLONING; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; GENETICS; IMAGE PROCESSING; LASER; MICRODISSECTION; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOLOGY; RETINA TUMOR; TUMOR SUPPRESSOR GENE;

AGE OF ONSET; ANTIBODIES, ANTI-IDIOTYPIC; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; GENES, RETINOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; LASERS; MICRODISSECTION; MUTATION; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN;

EID: 62849102338     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01070.x     Document Type: Article

References (56)

1. Knudson AG Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3.
2. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004; 24: 828-48.
3. Vogel F. Genetics of retinoblastoma. Hum Genet 1979; 52: 1-54.
4. Dimaras H, Khetan V, Halliday W et al. Loss of RB1 induces non-proliferative retinoma: Increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008; 17: 1363-72.
5. Sampieri K, Mencarelli MA, Epistolato MC et al. Genomic differences between retinoma and retinoblastoma. Acta Oncol 2008; 47: 1483-92.
6. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA. Retinoma: Spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 1982; 45: 513-21.
7. Margo C, Hidayat A, Kopelman J, Zimmerman LE. Retinocytoma: A benign variant of retinoblastoma. Arch Ophthalmol 1983; 101: 1519-31.
8. Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 1999; 59: 1731s-5s.
9. Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 2007; 46: 617-34.
10. Solinas-Toldo S, Lampel S, Stilgenbauer S et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997; 20: 399-407.
11. Pinkel D, Segraves R, Sudar D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-11.
12. Davies JJ, Wilson IM, Lam WL. Array CGH technologies and their applications to cancer genomes. Chromosome Res 2005; 13: 237-48.
13. Mairal A, Pinglier E, Gilbert E et al. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer 2000; 28: 370-9.
14. Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2001; 129: 57-63.
15. Herzog S, Lohmann DR, Buiting K et al. Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization. Hum Genet 2001; 108: 98-104.
16. Lillington DM, Kingston JE, Coen PG et al. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer 2003; 36: 121-8.
17. van der Wal JE, Hermsen MA, Gille HJ et al. Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group. J Clin Pathol 2003; 56: 26-30.
18. Zielinski B, Gratias S, Toedt G et al. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 2005; 43: 294-301.
19. Choy KW, Pang CP, Fan DS et al. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma. Invest Ophthalmol Vis Sci 2004; 45: 3404-9.
20. Dries D, Baca K, Truss L, Dobin S. Interstitial deletion of 13q and a 13; X chromosome translocation results in partial trisomy 13 and bilateral retinoblastoma. Ophthalmic Genet 2003; 24: 175-80.
21. Howard RO. Multiple changes in oncogenes and tumor suppressor genes in human retinoblastoma. Trans Am Ophthalmol Soc 1996; 94: 299-312.
22. Bowles E, Corson TW, Bayani J et al. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosomes Cancer 2007; 46: 118-29.
23. Wu L, Timmers C, Maiti B et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001; 414: 457-62.
24. Shu F, Lv S, Qin Y et al. Functional characterization of human PFTK1 as a cyclin-dependent kinase. Proc Natl Acad Sci USA 2007; 104: 9248-53.
25. Grasemann C, Gratias S, Stephan H et al. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene 2005; 24: 6441-9.
26. Orlic M, Spencer CE, Wang L, Gallie BL. Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosomes Cancer 2006; 45: 72-82.
27. Agata N, Ahmad R, Kawano T, Raina D, Kharbanda S., Kufe D. MUC 1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8. Cancer Res 2008; 68: 6136-44.
28. Raina D, Ahmad R, Kumar S et al. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J 2006; 25: 3774-83.
29. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133-40.
30. McGlade J, Cheng A, Pelicci G, Pelicci PG, Pawson T. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc Natl Acad Sci USA 1992; 89: 8869-73.
31. Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005; 24: 4741-53.
32. Laurie NA, Donovan SL, Shih CS et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444: 61-6.
33. Scott D, Elsden J, Pearson A, Lunec J. Genes co-amplified with MYCN in neuroblastoma: Silent passengers or co-determinants of phenotype? Cancer Lett 2003; 197: 81-6.
34. Godbout R, Packer M, Bie W. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. J Biol Chem 1998; 273: 21 161-8.
35. Hsu T, Trojanowska M, Watson DK. Ets proteins in biological control and cancer. J Cell Biochem 2004; 91: 896-903.
36. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003; 303: 11-34.
37. Yendamuri S, Trapasso F, Calin GA. ARLTS1 - a novel tumor suppressor gene. Cancer Lett 2008; 264: 11-20.
38. Calin GA, Trapasso F, Shimizu M et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005; 352: 1667-76.
39. Frank B, Meyer P, Boettger MB et al. ARLTS1 variants and melanoma risk. Int J Cancer 2006; 119: 1736-7.
40. Petrocca F, Iliopoulos D, Qin HR et al. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Res 2006; 66: 10 287-91.
41. Yendamuri S, Trapasso F, Ferracin M et al. Tumor suppressor functions of ARLTS1 in lung cancers. Cancer Res 2007; 67: 7738-45.
42. Bellan C, De Falco G, Tosi GM et al. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. Invest Ophthalmol Vis Sci 2002; 43: 3602-8.
43. Tosi GM, Trimarchi C, Macaluso M et al. Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: Implications for pathogenesis and therapeutic approach. Oncogene 2005; 24: 5827-36.
44. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 2004; 18: 1681-94.
45. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κ B. Nature 2003; 424: 797-801.
46. Weaver BA, Cleveland DW. Aneuploidy: Instigator and inhibitor of tumorigenesis. Cancer Res 2007; 67: 10 103-5.
47. Riggins GJ, Thiagalingam S, Rozenblum E et al. Mad-related genes in the human. Nat Genet 1996; 13: 347-9.
48. Chan GK, Liu ST, Yen TJ. Kinetochore structure and function. Trends Cell Biol 2005; 15: 589-98.
49. van Deursen JM. Rb loss causes cancer by driving mitosis mad. Cancer Cell 2007; 11: 1-3.
50. Kapic A, Helmbold H, Reimer R, Klotzsche O, Deppert W, Bohn W. Cooperation between p53 and p130 (Rb2) in induction of cellular senescence. Cell Death Differ 2006; 13: 324-34.
51. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247-59.
52. Gstaiger M, Jordan R, Lim M et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 2001; 98: 5043-8.
53. Sutterluty H, Chatelain E, Marti A et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1: 207-14.
54. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27 (Kip1) ubiquitination and degradation is regulated by the SCF (Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9: 661-4.
55. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1: 193-9.
56. Alexander K, Hinds PW. Requirement for p27 (KIP1) in retinoblastoma protein-mediated senescence. Mol Cell Biol 2001; 21: 3616-31.